GOLDENWELL BIOTECH, INC. Quarterly Operating Margin in % from Q4 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Goldenwell Biotech, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2022 to Q3 2024.
  • Goldenwell Biotech, Inc. Operating Margin for the quarter ending September 30, 2024 was -22.4K %, a 54.2% increase year-over-year.
  • Goldenwell Biotech, Inc. annual Operating Margin for 2022 was -2.06K %, a 178% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -22.4K +26.5K +54.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 -14.6K -12.4K -572% Apr 1, 2024 Jun 30, 2024
Q1 2024 -10.6K -8.6K -426% Jan 1, 2024 Mar 31, 2024
Q4 2023 -5K -2.93K -142% Oct 1, 2023 Dec 31, 2023
Q3 2023 -48.9K Jul 1, 2023 Sep 30, 2023
Q2 2023 -2.17K Apr 1, 2023 Jun 30, 2023
Q1 2023 -2.02K Jan 1, 2023 Mar 31, 2023
Q4 2022 -2.06K Oct 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.